| Literature DB >> 3708340 |
P J Whitehouse, A M Martino, P G Antuono, P R Lowenstein, J T Coyle, D L Price, K J Kellar.
Abstract
In Alzheimer's disease (AD), there is a loss of presynaptic cholinergic markers in the cerebral cortex, but the nature of cholinergic receptor changes is unclear. In this study, [3H]acetylcholine and [3H]nicotine were used to label nicotinic cholinergic binding sites in cerebral cortical tissues obtained at autopsy from patients with AD and from matched controls. A consistent and severe loss of nicotinic receptors was found in AD.Entities:
Mesh：
Substances：
Year: 1986 PMID： 3708340 DOI： 10.1016/0006-8993(86)90819-x
Source DB: PubMed Journal: Brain Res ISSN： 0006-8993 Impact factor: 3.252